Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 15/20 | 0.61 |
| ▸ | METAP1 | P53582 | 8/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7361788 | 0.99 | METAP2 (0.60) | METAP2METAP1KMT2ATSHRP2RX7 | |
| SCHEMBL6477713 | 0.88 | METAP2 (0.72) | METAP2METAP1P2RX7 | |
| SCHEMBL7351163 | 0.86 | METAP2 (0.59) | METAP2METAP1 | |
| Hydrochloric Acid SCHEMBL7362241 | 0.85 | METAP2 (0.58) | METAP2METAP1 | |
| SCHEMBL7359944 | 0.85 | METAP2 (0.61) | METAP2METAP1 | |
| SCHEMBL14984957 | 0.85 | KMT2A (0.55) | METAP2METAP1KMT2ATSHRP2RX7 | |
| SCHEMBL7361746 | 0.85 | METAP2 (0.64) | METAP2METAP1TSHR | |
| SCHEMBL7351644 | 0.84 | METAP2 (0.54) | METAP2METAP1 | |
| SCHEMBL19350686 | 0.83 | KMT2A (0.50) | METAP2METAP1KMT2ATSHRP2RX7 | |
| SCHEMBL12022071 | 0.83 | KMT2A (0.53) | METAP2METAP1KMT2ATSHRP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6242494-B1 | ANGIOGENESIS INHIBITORS, ANTITUMOR AGENTS, DIABETIC RETINOPATHY, AND ANTIINFLAMMATORY AGENTS | ABBOTT LABORATORIES | 2001-06-05 | — | — | US | claimed |
| EP-1073633-A2 | SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 | ABBOTT LABORATORIES (US) | 2001-02-07 | — | — | EP | claimed |
| WO-1999057098-A2 | SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 | ABBOTT LABORATORIES (US) | 1999-11-11 | — | — | WO | claimed |
| US-6242494-B1 | ANGIOGENESIS INHIBITORS, ANTITUMOR AGENTS, DIABETIC RETINOPATHY, AND ANTIINFLAMMATORY AGENTS | ABBOTT LABORATORIES | 2001-06-05 | — | — | US | disclosed |
| EP-1073633-A2 | SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 | ABBOTT LABORATORIES (US) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999057098-A2 | SUBSTITUTED BETA-AMINO ACID INHIBITORS OF METHIONINE AMINOPEPTIDASE-2 | ABBOTT LABORATORIES (US) | 1999-11-11 | — | — | WO | disclosed |